Condition: Kbg Syndrome · ADHD - Combined Type · Sponsor: Radboud University Medical Center
The goal of this clinical trial\] is to learn about the effect of methylphenidate in children and adolescents with KBG syndrome. The main question it aims to answer is: • What is the effectiveness of methylphenidate on attention deficit and ADHD-related symptoms in children and adolescents with KBG syndrome? Participants will receive multiple blocks of treatment with methylphenidate and placebo and fill out various questionnaires.
This description comes directly from the study's public registry record.
Charlotte Ockeloen, MD · +31243613946 · charlotte.ockeloen@radboudumc.nl
Always discuss trial participation with your own doctor first.
| Radboud University Medical Center | Nijmegen, Gelderland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06465641